Abel Hall LLC
AMRX icon

Abel Hall LLC’s Amneal Pharmaceuticals AMRX Stock Holding History

Abel Hall LLC’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$235K Buy
11,686
+328
+3% +$5.91K 0.04% 580
2026
Q2 		$197K Buy
11,358
+828
+8% +$11.3K 0.03% 746
2026
Q1 		$131K Sell
10,530
-8,772
-45% -$118K 0.03% 671
2025
Q4 		$243K Buy
+19,302
New +$221K 0.06% 445

Other funds holding AMRX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Tucker Asset Management
Tucker Asset Management Littleton, Colorado $406M AUM 20.49% 1-Year Est. Return
Exchange Traded Concepts
Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return
Signature Wealth Management Partners
Signature Wealth Management Partners Montvale, New Jersey $234M AUM 23.06% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Diversify Advisory Services
Diversify Advisory Services Sandy, Utah $6.69B AUM 18.85% 1-Year Est. Return
Diversify Wealth Management
Diversify Wealth Management Sandy, Utah $6.69B AUM 22.4% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

Abel Hall LLC's AMRX Position: Q3 2026 in Review

Abel Hall LLC increased its Amneal Pharmaceuticals (AMRX) stake by 2.9% in Q3 2026, buying an estimated $5.91K and bringing the position to 11,686 shares worth $235K. The position accounts for 0.04% of the portfolio, ranked #580.

Abel Hall LLC first reported a position in AMRX in Q4 2025 and has held it in 4 quarters since. The position peaked at $243K in Q4 2025. 95 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.

  • Abel Hall LLC held 11,686 shares of Amneal Pharmaceuticals worth $235K as of Q3 2026.
  • Abel Hall LLC bought 328 Amneal Pharmaceuticals shares in Q3 2026, an estimated $5.91K.
  • Amneal Pharmaceuticals made up 0.04% of Abel Hall LLC's portfolio in Q3 2026, its #580 holding.
  • Abel Hall LLC first reported a position in Amneal Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
  • Abel Hall LLC's Amneal Pharmaceuticals position peaked at $243K in Q4 2025.
  • 95 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.